BetaShares Global Healthcare ETF - Currency Hedged (ASX: DRUG) Share Price and News
Price
$7.66
Movement
0.02 (-0.26%)
as at 17 Apr - Closed (20 mins delayed)
52 Week Range
$7.33 - $9.17
1 Year Return
-6.01%
BetaShares Global Healthcare ETF - Currency Hedged Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
$7.66
Day Change
0.02 (-0.26%)
52 Week Range
$7.33 - $9.17
Yesterday's Close
$7.68
Today's Open
$7.69
Days Range
$7.63 - $7.69
Volume
55,803
Avg. Volume (1 month)
58,631
Turnover
$427,704
as at 17 Apr - Closed
BetaShares Global Healthcare ETF - Currency Hedged (ASX: DRUG)
Latest News
Defensive Shares
3 defensive ETFs to navigate volatility on the ASX
ETFs
How to invest in US weight loss drug stocks on the ASX
Healthcare Shares
How can ASX investors buy the US stock the WHOLE world is talking about?
ETFs
'Beyond our expectations': How to invest in obesity drugs like Ozempic with ASX ETFs
ETFs
3 defensive ASX ETFs to buy if a recession comes
ETFs
Expert names 2 excellent ASX ETFs to buy
ETFs
Expert names the ETFs to buy this month
ETFs
Betashares names 6 'defensive' ASX ETFs to consider for a possible recession
ETFs
A defensive ASX ETF for a recessionary environment: experts
Share Market News
ETF provider VanEck to launch 4 new ASX ETFs
DRUG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Edward Sippel | Non-Executive Director | Mar 2021 |
No profile reported in annual report
|
| Mr Alex Vynokur | Executive Director | Sep 2009 |
Mr Vynokur is responsible for leading the strategy and overall management of the business. Alex was involved in the establishment and development of Australian financial services businesses including Pengana Capital and Centric Wealth. Alex is a director and principal of Apex Capital Partners. He is also a director of Toranotec Ltd. Alex previously worked at Turnbull Pillemer Capital, where he focussed on identifying and managing investments across the financial services industry. Prior to commencing his career in financial services, Alex was a lawyer at Baker & McKenzie, specialising in mergers and acquisitions and financial services.
|
| Mr Jason Gellert | Executive Director | Mar 2021 |
No profile reported in annual report
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| No Top 20 Shareholder Information | 0 | 0.00% |